These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12643128)

  • 1. The role of the immune system in the insulin resistance syndrome.
    Lewis MR; Tracy RP
    Curr Diab Rep; 2002 Feb; 2(1):96-9. PubMed ID: 12643128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On par with PPARs.
    Akiyama TE; Nicol CJ; Gonzalez FJ
    Trends Genet; 2001 Jun; 17(6):310-12. PubMed ID: 11424916
    [No Abstract]   [Full Text] [Related]  

  • 3. No interactions between polymorphisms in the beta3-adrenergic receptor gene and the PPAR-gamma gene on the risk of the insulin resistance syndrome in the Danish MONICA cohort.
    Frederiksen L; Brødbaek K; Fenger M; Madsbad S; Urhammer SA; Jørgensen T; Borch-Johnsen K
    Diabetologia; 2003 May; 46(5):729-31. PubMed ID: 12739018
    [No Abstract]   [Full Text] [Related]  

  • 4. PPAR gamma and the treatment of insulin resistance.
    Olefsky JM; Saltiel AR
    Trends Endocrinol Metab; 2000 Nov; 11(9):362-8. PubMed ID: 11042466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into insulin resistance and type 2 diabetes from knockout mouse models.
    Kadowaki T
    J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
    Olefsky JM
    J Clin Invest; 2000 Aug; 106(4):467-72. PubMed ID: 10953021
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin resistance and obesity.
    Schwartz MW; Kahn SE
    Nature; 1999 Dec 23-30; 402(6764):860-1. PubMed ID: 10622250
    [No Abstract]   [Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics.
    Chatterjee VK
    Horm Res; 2003; 60 Suppl 3():51-5. PubMed ID: 14671397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity as a link between obesity and insulin resistance.
    Kalupahana NS; Moustaid-Moussa N; Claycombe KJ
    Mol Aspects Med; 2012 Feb; 33(1):26-34. PubMed ID: 22040698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The mechanisms by which PPAR gamma regulates fat storage and insulin sensitivity].
    Yamauchi T; Hara K; Miki H; Kadowaki T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():489-97. PubMed ID: 11351636
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.
    Globerman H; Zauberman Y; Makarov T; Beamer BA; Yen CJ; Shuldiner AR; Harel C; Karnieli E
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):479-85. PubMed ID: 10762291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance.
    Winer S; Winer DA
    Immunol Cell Biol; 2012 Sep; 90(8):755-62. PubMed ID: 22231651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of insulin resistance.
    Mercado MM; McLenithan JC; Silver KD; Shuldiner AR
    Curr Diab Rep; 2002 Feb; 2(1):83-95. PubMed ID: 12643127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin resistance physiopathology].
    Boulogne A; Vantyghem MC
    Presse Med; 2004 Jun; 33(10):666-72, 681. PubMed ID: 15257241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Signaling mechanism in the regulation of osteoclast differentiation by the immune system].
    Takayanagi H
    Seikagaku; 2003 Dec; 75(12):1535-40. PubMed ID: 14748148
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of PPARgamma in the onset of type 2 diabetes].
    Hara K; Yamauchi T; Kubota N; Tobe K; Yamazaki T; Nagai R; Kadowaki T
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):317-24. PubMed ID: 14501167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in our understanding of insulin action and insulin resistance.
    Le Roith D; Zick Y
    Diabetes Care; 2001 Mar; 24(3):588-97. PubMed ID: 11289486
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenomics, lipodystrophy, and the metabolic syndrome.
    Hegele RA
    Trends Cardiovasc Med; 2004 May; 14(4):133-7. PubMed ID: 15177263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links.
    Zafar U; Khaliq S; Ahmad HU; Manzoor S; Lone KP
    Hormones (Athens); 2018 Sep; 17(3):299-313. PubMed ID: 30171523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.